• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Martin Metz

Germany

Martin Metz

Sessions

Saturday 14 Jun
09:00 - 10:00
SAT12 Celldex - Shining a Light on Mast Cells in Chronic Spontaneous Urticaria Sponsored Sessions Boisdale
09:25 - 09:40 CSU: Mechanism of Disease
15:00 - 15:12 Initial Results from SPOTLIGHT, a Phase 1b/2a Dose Escalation Study of the anti-c-Kit Briquilimab Antibody in Adults with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite H1-Antihistamine Treatment
15:48 - 16:00 Treatment with Barzolvolimab Leads to Sustained Improvement in Angioedema in Chronic Spontaneous Urticaria (CSU) patients: Results from 52 Weeks of Treatment
Sunday 15 Jun
13:20 - 13:27 Briquilimab Demonstrates Rapid, Clinically Meaningful Disease-Control in Adults with Chronic Spontaneous Urticaria (CSU): Updated Results from a Phase 1b/2a Study
×